ABSTRACT
Introduction
The effects of inhalational anesthetic agents on myocardial contraction have been the focus of extensive investigations for many years, and the depression of force development by different inhalational agents has been repeatedly shown. At the cellular level, altered cardiac excitation-contraction coupling has been identified as a major vehicle of impaired cardiac performance. In fact, inhalational anesthetics have been shown to decrease sarcolemmal L-type Ca 2ϩ channel function (Terrar and Victory, 1988) , decrease sarcoplasmic reticular Ca 2ϩ storage (Davies et al., 2000) , Ca 2ϩ release (Jiang and Julian, 1998) , and decrease myofilament Ca 2ϩ sensitivity (Bosnjak et al., 1992; Davies et al., 2000) . More importantly, it appears that the impact of inhalational agents on myocardium is agent-and dose-dependent, with decreasing Ca 2ϩ availability being viewed as the major mode of action based on previous studies (Rusy and Komai, 1987; Housmans and Murat, 1988; Housmans et al., 2000) .
However, other recent studies have shown that, at clinical dosages (i.e., 0.5-1.5 minimum alveolar concentration), isoflurane (ISO) or sevoflurane differentially decrease contractile force development while producing little inhibition of Ca 2ϩ release. This point is proven by the lack of change in the amplitudes of intracellular Ca 2ϩ transients (Hanley and Loiselle, 1998; Bartunek and Housmans, 2000; Davies et al., 2000; Graham et al., 2005) . This clearly hints at the possibility that ISO directly decreases myofilament Ca 2ϩ responsiveness. Nonetheless, early studies that used skinned cardiac muscle preparations yielded variable results; some failed to show any effect of ISO at low concentrations (i.e., clinically relevant doses: 1-3%) (Su and Kerrick, 1980; Su and Bell, 1986) , and others showed either increased or decreased myofilament Ca 2ϩ sensitivity Herland et al., 1993) . The contention was that the presence of a cellular membrane system could influence the modulation of cardiac inotropy by inhalational agents (Herland et al., 1993) . Thus, it remains unclear whether ISO affects myofilament function per se, i.e., independently from changes induced at the sarcolemmal level.
Nitroxyl (HNO), the protonated one-electron reduction product of nitric oxide (Tocchetti et al., 2011) , augments cardiac inotropy and improves relaxation in dog hearts, both under normal and heart failure conditions (Paolocci et al., 2001 (Paolocci et al., , 2003 . The positive inotropic and lusitropic effects of HNO are independent of ␤-adrenergic stimulation but are sensitive to the redox states of the cardiac cell Froehlich et al., 2008) . Recently, we found that HNO augments cardiac contractility by increasing Ca 2ϩ responsiveness of the myofilaments (Dai et al., 2007) . This enhancement of force is not associated with an increase in diastolic tension or myofibrillar Mg-ATPase activities. Subsequently, we have confirmed that HNO, by interacting with specific, highly reactive thiols in myofilament proteins, modifies the redox states of key contractile proteins, thus promoting an increase in force production after Ca 2ϩ binds to troponins (Tn) (Murray et al., 2009) .
In this study, we tested two main hypotheses. First, we aimed to verify whether ISO is able to exert a direct effect on myofilament sensitization to Ca 2ϩ . To do so, we determined the steady-state force-Ca 2ϩ relations of individual muscles, before and after skinning. Our second aim was to test whether the HNO donor, 1-nitrosocyclohexyl acetate (NCA) (Sha et al., 2006; Shoman et al., 2011) , can restore cardiac force development in the presence of ISO by virtue of its Ca 2ϩ -sensitizing effect (Dai et al., 2007) . We hope to demonstrate that HNO, donated by NCA, can restore myocardial contractility during ISO-induced anesthesia and that HNO donors are probably able to provide an inotropic counterbalancing effect in patients displaying compromised cardiac function due to inhalation of volatile anesthetics such as ISO, thus justifying the use of HNO donors for patients with heart failure undergoing inhalational anesthesia.
Materials and Methods
Animals. LBN/F1 rats (250 -300 g; Harlan, Indianapolis, IN) were used in these experiments. Animal care and experimental protocols were approved by the Animal Care and Use Committee of The Johns Hopkins University School of Medicine.
Trabecular Muscle Preparation. The rats were anesthetized via intra-abdominal injection with pentobarbital (100 mg/kg); the heart was exposed by mid-sternotomy, rapidly excised, and placed in a dissection dish. The aorta was cannulated, and the heart was perfused in a retrograde fashion (ϳ15 ml/min) with dissecting KrebsHenseleit (K-H) solution equilibrated with 95% O 2 , 5% CO 2 . The dissecting K-H solution was composed of 120 mM NaCl, 20 mM NaHCO 3 , 5 mM KCl, 1.2 mM MgCl 2 , 10 mM glucose, 0.5 mM CaCl 2 , and 20 mM 2,3-butanedione monoxime, pH 7.35 to 7.45 at room temperature (21-22°C). Trabecular muscle from the right ventricle of the heart was dissected and mounted between a force transducer and a motor arm, superfused with K-H solution without 2,3-butanedione monoxime at a rate of ϳ10 ml/min, and stimulated at 0.5 Hz.
Force was measured by a force transducer system (KG7; Scientific Instruments GmbH, Heidelberg, Germany) and expressed in millinewtons per square millimeter of cross-sectional area. The muscles underwent isometric contractions with the resting muscle length set, such that resting force was 15% of total force development (i.e., optimal muscle length). This resting muscle length, corresponding to resting sarcomere length of 2.20 to 2.30 m as determined by laser diffraction (Gao et al., 1996) , was maintained throughout the experiments. ISO was delivered via an ISO-specific vaporizer (calibrated by a vapor analyzer) to the K-H solution along with the 95% O 2 , 5% CO 2 gas mixture at a constant flow rate (1.0 l/min). The K-H solution was bubbled through a fine-porosity gas distribution tube with desired doses (vol %) of ISO for at least 15 min before use. Because of the volatile nature of ISO, the K-H solution was constantly bubbled with the gas mixture saturated with ISO, and the reservoir was covered to maintain the desired percentage of ISO throughout the experiments. In this design, the muscles were superfused with K-H buffer saturated with desired percentage of ISO (i.e., not via inhalation). NCA was dissolved in dimethyl sulfoxide to make a stock solution (0.06 M) and stored in Ϫ20°C until use. All experiments were performed at room temperature (20°C-22°C).
Measurement of [Ca 2؉ ] i . Intracellular Ca 2ϩ ([Ca 2ϩ ] i ) was measured by using the free acid form of fura-2 as described previously (Gao et al., 1994; Dai et al., 2007) . Fura-2 potassium salt was microinjected iontophoretically into one cell and allowed to spread throughout the whole muscle (via gap junctions). The tip of the electrode (ϳ0.2 m in diameter) was filled with fura-2 salt (1 mM), and the remainder of the electrode was filled with 150 mM KCl. After a successful impalement into a superficial cell in nonstimulated muscle, a hyperpolarizing current of 5 to 10 nA was passed continuously for approximately 15 min. In some muscles, multiple injections (up to 3-4) were applied at different sites, with duration of the injection limited to Ͻ10 min at each site to achieve an optimal signal-to-noise ratio. As previously established, this loading did not affect force development. Fura-2 epifluorescence was measured by excitation at 380 and 340 nm. Fluorescent light was collected at 510 nm by a photomultiplier tube (R1527; Hamamatsu Photonics, Hamamatsu City, Japan). The output of the photomultiplier was collected and digitized. [Ca 2ϩ ] i was given by the following equation (after subtraction of the autofluorescence) (eq. 1):
where R is the observed ratio of fluorescence (340 nm/380 nm), KЈ d is the apparent dissociation constant, R max is the ratio of 340 nm/380 nm at saturating Ca 2ϩ , and R min is the ratio of 340 nm/380 nm at 0 Ca 2ϩ . The values of KЈ d , R max , and R min were determined by in vivo calibrations as described previously (Gao et al., 1994 (Gao et al., , 1998 .
Steady-State Activation of Trabeculae. Ryanodine (1.0 M) was used to enable steady-state activation. After the muscles were exposed to ryanodine for 15 min, different levels of tetanizations were induced briefly (ϳ4 -8 s) by stimulating the muscles at 10 Hz at various concentrations of extracellular Ca 2ϩ ([Ca 2ϩ ] o ; 0.5-20 mM). The steady-state force- [Ca 2ϩ ] relations were fit with a function of the Hill equation (eq. 2):
where F is the steady-state force at various Ca 2ϩ concentrations, F max is the maximal Ca 2ϩ -activated force, Ca 50 is the Ca 2ϩ concentration required to achieve 50% F max , and n is the Hill coefficient.
Skinned Trabeculae. After the steady-state experiments, the same trabeculae were immediately skinned by 15 to 20 min of exposure to 1% Triton X-100 in relaxing solution containing 100 mM KCl, 25 mM HEPES, 10 mM K 2 EGTA, 15 mM creatine phosphate sodium 826 Ding et al.
salt (Na 2 CrP), 5 mM Na 2 ATP, 5.15 mM MgCl 2 , and 0.5 mM leupeptin, pH 7.2 with KOH. Activating solution contained 10 mM Ca 2ϩ -EGTA, 100 mM KCl, 25 mM HEPES, 15 mM Na 2 CrP, 5 mM Na 2 ATP, 4.75 mM MgCl 2 , and 0.5 mM leupeptin, pH 7.2. Different Ca 2ϩ concentrations were achieved by mixing the activating solution and relaxing solution at different ratios. Skinning was considered to be complete when the preparation lost its pink color and sarcomeres were visible. Diastolic sarcomere length was determined by direct visualization under 100ϫ magnification and was set at ϳ2.2 m. Resting force was usually 10 to 15% of maximal activated force at this sarcomere length. The force-Ca 2ϩ relationship was obtained by exposing the skinned muscles to activating solutions with various Ca 2ϩ concentrations and were fit with the Hill equation as described above.
Statistical Analysis. Paired Student's t test and multivariate ANOVA were used for statistical analysis of the data (Systat 10.2.01; Systat Software Inc., San Jose, CA). A value of P Ͻ 0.05 was considered to indicate significant differences between groups. Unless otherwise indicated, pooled data are expressed as means Ϯ S.E.M. [Ca 2ϩ ] i was reduced by only 15% (to 0.5 Ϯ 0.05 m, P Ͼ 0.05). Thus, after treatment with ISO, the reduction of force seen seems to stem from changes in the properties of the myofilament (i.e., decreased myofilament Ca 2ϩ responsiveness), rather than from decreased Ca 2ϩ cycling/availability. In addition, relaxation of twitch force, as measured by time to half-relaxation from peak force, was faster in the presence of ISO (Table 1) .
Results

Isoflurane Depresses Twitch
Isoflurane Decreases Myofilament Ca 2؉ Responsiveness. The data presented above only indirectly supports the contention that myofilament properties change under the influence of ISO given that, during activation and contraction, peak force development and peak amplitude of the [Ca 2ϩ ] i transient are not at equilibrium. Thus, to unequivocally prove that the anesthetic has a primary effect on myofilaments, we measured the steady-state force- [Ca 2ϩ ] i rela- Fig. 2A ; Table 2 ). The Hill coefficient was not affected in these muscles. Overall, there is a significant difference between the two relationships (P Ͻ 0.001) when multivariate ANOVA was performed among the parameters of F max , Ca 50 , and Hill coefficient. Hence, the action of ISO in the intact muscle was to decrease F max and increase Ca 50 .
In the intact muscle, the myofilaments are bathed in a cellular milieu that contains many factors that modulate the steady-state force- [Ca 2ϩ ] i relationship (Gao et al., 1997) . ISO could potentially modify these factors, thereby decreasing myofilament Ca 2ϩ responsiveness. Therefore, to rule out all potential confounding factors, we skinned the same trabecular muscle in which the steady-state force- [Ca 2ϩ ] i relations had been obtained. This enabled us to obtain force- [Ca 2ϩ ] relations devoid of potential soluble confounding factors in these muscles. Likewise, in these skinned muscles, the F max and Ca 50 were significantly depressed ( Fig. 2B; Table 2 ) in the presence of ISO. Multivariate ANOVA also showed significant difference between the two relationships (P Ͻ 0.001). Thus, the depressing effect of ISO on the steady-state forceCa 2ϩ relation persisted in skinned muscles. We also performed experiments in which trabeculae were chemically skinned immediately after stabilization and the force-Ca 2ϩ relationship was obtained in the absence or presence of 1.5% ISO. These experiments served as internal checkpoints for the tetanization protocol performed to verify that the protocol itself did not affect the force-Ca 2ϩ in the (same) skinned muscles afterward. Indeed, these experiments showed identical force-Ca 2ϩ relations as in Fig. 2B , indicating that tetanization protocol had no effect on subsequent force-Ca 2ϩ relations in skinned muscles (Fig. 3) . Thus, all together these data strongly support our initial hypothesis that the ISOinduced negative effect on myocardial contraction largely stems from a direct adverse impact on the myofilament.
Reversal of the Negative Inotropic Effect of Isoflurane. If ISO inhibits force generation by directly decreasing myofilament Ca 2ϩ responsiveness, agents that increase myofilament Ca 2ϩ responsiveness (so-called Ca 2ϩ sensitizers) should be able to restore force in the presence of this anesthetic agent. We tested this hypothesis by exposing the muscles to the new HNO donor, NCA (Sha et al., 2006 ; DuMond and King, 2011; Shoman et al., 2011). As we learned earlier, Fig. 2 . Steady-state force Ca 2ϩ relations in the presence and absence of ISO (1.5%) in isolated intact and skinned cardiac trabecular muscles. The steady-state forces were plotted against amplitudes of [Ca 2ϩ ] i that were grouped into bins in 0.5 M ranges. A, in intact trabeculae, F max was significantly reduced, whereas Ca 50 was significantly increased by ISO. B, the same muscles in which steady-state relations were first obtained were chemically skinned and activated with various Ca 2ϩ concentrations. The effect of ISO on F max and Ca 50 persisted in these skinned muscles. Temperature ϭ 22°C; n ϭ 7. Fig. 3 . Effect of ISO on steady-state force-Ca 2ϩ relations in skinned trabeculae. After stabilization, these muscles were immediately skinned chemically with 1% Triton X-100. Different levels of forces were obtained by activating the muscles with varying Ca 2ϩ concentrations. ISO decreased F max from 66.6 Ϯ 2.7 to 47.8 Ϯ 4.3 mN/mm 2 , P Ͻ 0.05, paired t test) and increased Ca 50 from 1.45 Ϯ 0.12 to 2.35 Ϯ 0.37 M, P Ͻ 0.05), n ϭ 5. (Murray et al., 2009 ). At 5 M (slightly higher than the EC 50 of NCA as determined in cardiac muscle (Murray et al., 2009) , NCA increased force development significantly without affecting twitch dynamics (Table 1) . It is noteworthy that NCA completely restored force development in the presence of 1.5% ISO, with little increase in the amplitude of the [Ca 2ϩ ] i transient (Fig. 4) . To show that NCA was indeed effective, we compared force recovery and [Ca 2ϩ ] i transient amplitude when [Ca 2ϩ ] o was raised (Fig. 5) . Although ISO-dependent force depression could be fully restored by increasing the [Ca 2ϩ ] o , the [Ca 2ϩ ] i more than doubled. In contrast to Ca 2ϩ , NCA produced a full recovery in force without increasing [Ca 2ϩ ] i . It is noteworthy that levosimendan (Levo), another Ca 2ϩ -sensitizing agent, which binds to cardiac TnC (Haikala et al., 1995) , hardly restored force in the presence of ISO (Fig. 6) , although it was able to increase force development in the absence of it as expected (Sato et al., 1998) . This suggests that ISO affects steps downstream of Tn activation in myofilament contraction.
Discussion
In this study, we provide two novel findings. First, we demonstrated that ISO is able to reduce force development without affecting the intracellular Ca 2ϩ transient. For the first time, we show that ISO decreased F max and increased Ca 50 of the steady-state force-Ca 2ϩ relation in individual muscles, both before and after they were chemically skinned. Second, we demonstrated the ability of HNO donors such as NCA to rescue force development in ISO-treated muscles by virtue of their sensitizing action to Ca 2ϩ at the myofilament level. This study extended the results from previous investigations on the effect of ISO on myocardial contractility while deepening our understanding of how ISO may dampen myocardial function.
The myofilament desensitizing effect of ISO (and/or sevoflurane) has been shown by a number of prior studies in intact cardiac muscles and myocytes (Hanley and Loiselle, 1998; Jiang and Julian, 1998; Graham et al., 2005) . ISO may decrease myofilament Ca 2ϩ responsiveness by 1) directly interacting with the contractile proteins to affect activation/ contraction processes and 2) modifying soluble cytoplasmic factors that may influence the behavior of the myofilaments. These pathways can be removed by skinning the muscle preparation; thus, the environment bathing the myofilaments proteins can be controlled. By equalizing the composition of solutions bathing the myofibrils, any of the effects of ISO observed is the result of a direct interaction between the agents and the contractile proteins. On the other hand, the results of previous studies using skinned muscle preparations have been variable; some have shown that myofilament (doses titrated to achieve complete recovery of force development, n ϭ 4) or NCA (5 M, n ϭ 4) was added to the perfusion solution. Force was completely restored by raising [Ca 2ϩ ] o , but [Ca 2ϩ ] i transients more than doubled. NCA restored force development with little increase in [Ca 2ϩ ] i transients. Temperature ϭ 22°C; stimulation rate ϭ 0.5 Hz. ‫,ء‬ P Ͻ 0.05 versus all other groups for force development; #, P Ͻ 0.05 versus all other groups for [Ca 2ϩ ] i transients. ‫,ءء‬ P Ͻ 0.05 versus all other groups for force development. 
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Ca 2ϩ responsiveness to inhalational anesthetics decreased (Herland et al., 1993) , whereas others have shown no change or increased myofilament Ca 2ϩ responsiveness (Su and Kerrick, 1980; Su and Bell, 1986; Murat et al., 1988) . Taken together, these studies suggest that, at least in part, the myofilament desensitization may reflect changes in the soluble cytoplasmic factors. Therefore, we chose to try another approach to evaluate the effect of ISO on myofilament Ca 2ϩ responsiveness using the same muscle before and after skinning. This is a technically challenging experimental design that allows us to neatly distinguish the relative roles of soluble cytoplasmic factors and myofilament proteins in ISOinduced force depression, directly with increased reliability. The decreased myofilament Ca 2ϩ responsiveness induced by ISO in intact muscles was reproducible in the same skinned muscles, confirming a direct myofilament effect of ISO.
The mechanism by which ISO interacts with myofilaments to decrease force development is not known at the moment. In cardiac muscle, force development depends on this sequence of events: Ca 2ϩ binding to TnC (Krudy et al., 1994) , interactions between Tn subunits (Kleerekoper et al., 1995; Dong et al., 2003) , Tn-tropomyosin-actin interactions (McKillop and Geeves, 1993; Gordon et al., 2000; Lehman et al., 2001) , and cross-bridge formation to generate force (Geeves and Holmes, 2005; Fujita-Becker et al., 2006) . ISO has been shown to increase TnC affinity for Ca 2ϩ and to promote conformational changes within Tn (Breukelmann and Housmans, 2007) : however, such changes would not be expected to decrease force. In in vitro motility assays, ISO does not interfere with cross-bridge formation between isolated myosin and actin (Vivien et al., 2005) . The inability of Levo, another known myofilament Ca 2ϩ sensitizer that binds TnC and stabilizes the conformation of Ca 2ϩ -Tn complex (Haikala et al., 1995) , to restore force in the presence of ISO suggests that ISO probably targets process(es) after TnC activation. Thus, given the above considerations, actin-tropomyosin interactions are most probably targeted by ISO. The fact that HNO provides complete (and competitive) reversal of ISOinduced force depression without additional increases in intracellular Ca 2ϩ provides strong support to our view that HNO increases force development by increasing myofilament Ca 2ϩ responsiveness (Dai et al., 2007; El-Armouche et al., 2010) . Recently, we have shown that HNO promotes formation of disulfide bridges between actin and tropomyosin. These disulfide bridges prime tropomyosin for exposing more force-generating cross-bridge binding sites on actin so that more force could be produced (Murray et al., 2009 ). However, the molecular nature of isoflurane's action on myofilament proteins is unknown. Ongoing studies in our laboratory are focusing on identifying the myofilament protein(s) that are targeted by ISO.
Our current findings have some important pragmatic implications. The negative inotropic effect of ISO is probably to depress contractility further in patients with heart failure under anesthesia. Routinely, vasoconstrictors (i.e., phenylephrine) and crystalloid are administered to restore blood pressure and maintain cardiac output. In spite of these therapies, the perioperative morbidity and mortality for patient with heart failure is surprisingly high (i.e., 11.7%) (Hernandez et al., 2004) . It is conceivable that vasoconstrictors and fluid therapy may impair the capability of the heart to contract due to an increase in pre-and postload. On the other hand, positive inotropic agents are expected to be more effective because they can augment cardiac contractility but they tend to produce Ca 2ϩ overload. Ca 2ϩ sensitizers, which represent a new class of inotropic agents, may be an effective alternative (Kass and Solaro, 2006) . Their potential is especially relevant for patients with heart failure who require anesthesia. Decreased myofilament Ca 2ϩ responsiveness as a result of alterations in the function of myofilament regulatory proteins is a significant contributor to the severely decreased contractility of failing myocardium (Noguchi et al., 2004; VanBuren and Okada, 2005; Murphy, 2006) . Thus, inotropic agents with Ca 2ϩ -sensitizing properties are more desirable and probably more efficient for restoring contractility than conventional inotropic agents that increase contractility simply by increasing the availability of Ca 2ϩ (Brixius et al., 2005; Hasenfuss and Teerlink, 2011) . In addition, because of the exaggerated Ca 2ϩ overload, the use of conventional inotropic agents is associated with worsening morbidity and mortality in heart failure patients (Cohn et al., 1998; Cuffe et al., 2002) . Another aspect that singles NCA/ HNO out among other inotropes is that it does not alter ISO-induced impact on lusitropy (Table 1) .
In summary, we demonstrated that, at clinically relevant doses, the inhalational anesthetic ISO directly depresses myofilament contractility by decreasing Ca 2ϩ responsiveness. The force depression can be effectively and fully restored by the novel myofilament Ca 2ϩ sensitizer, NCA. Ca 2ϩ can also restore the loss in force depression, but only with concomitant doubling of [Ca 2ϩ ] i . Although the molecular nature of ISO's myofilament action is still under investigation, our findings indicate that cardiac depression during anesthesia, especially in patients with heart failure, is more effectively and efficiently treated with positive inotropic agents that possess Ca 2ϩ -sensitizing properties.
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